NRXP
NRX Pharmaceuticals Inc
3.00$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -1,152.0% | |
| – | – | – | – | – | – | – | – | 11.7% | |
| – | – | – | – | – | – | – | – | 18.6% | |
| – | – | – | – | – | – | – | – | 115.0% | |
| – | – | – | – | – | – | – | – | 0.0% | |
| – | – | – | – | – | – | – | – | -229.4% | |
| – | – | – | – | – | – | – | – | 382.0% | |
| – | – | – | – | – | – | – | – | 1,900.1% | |
| – | – | – | – | – | – | – | – | 518.7% | |
| – | – | – | – | – | – | – | – | -1,152.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.